Drugs / MVA/HIV62B
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04357821 | Aug 2020 → Jun 2026 overdue | HIV infectious disease | University of California, San Francisco | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MVA/HIV62B | “MVA/HIV62B (MVA62B) boost” NCT04357821 ↗ |
| Known as | MVA62B | “MVA/HIV62B (MVA62B) boost” NCT04357821 ↗ |